文献速递围术期管理与 ERAS

全动脉化冠状动脉旁路移植术208例手术策略与远期结局

[Surgical strategies and long-term outcomes of total arterial coronary artery bypass grafting: a series of 208 patients].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2020-01-01

该研究回顾性分析2009年2月至2019年12月上海交通大学医学院附属瑞金医院心脏外科208例全动脉化冠状动脉旁路移植术(CABG)患者的临床资料,30天病死率1.4%,随访(5.4±2.8)年,10年全因病死率6.9%、主要严重心脑血管事件(MACCE)28.5%、再次血运重建11.9%,年龄>65岁是远期死亡独立预后因素。结论认为在合适患者选择和个体化手术方案下全动脉化CABG安全可行。

要点

  • 全动脉化CABG术后30天病死率1.4%(3/208),围手术期MACCE 1.9%(4/208)。
  • 随访(5.4±2.8)年,10年全因病死率6.9%、MACCE 28.5%、再次血运重建11.9%。
  • 年龄>65岁是远期死亡的独立预后因素(HR=1.125,95%CI:1.050~1.205,P<0.01)。

核心结论

  • 全动脉化CABG在合适患者选择和个体化手术方案下安全可行,可降低远期病死率和再次血运重建风险。

研究设计与样本

  • 回顾性分析2009年2月至2019年12月上海交通大学医学院附属瑞金医院心脏外科208例全动脉化CABG患者,男188例、女20例,年龄(54.7±10.7)岁(范围:32~79岁)。
  • 非体外循环CABG占98.1%(204/208),每例移植血管(2.6±0.7)支(范围:2~4支)。
  • 分组比较双侧胸廓内动脉组(37例)与单侧胸廓内动脉加桡动脉组(171例)。

主要发现

  • 术后30天总体病死率1.4%(3/208),围手术期MACCE 1.9%(4/208),出血二次开胸0.5%(1/208),深部胸部切口感染1.4%(3/208),围手术期无心肌梗死和再次血运重建。
  • 双侧组与单侧组30天病死率、MACCE、出血、深部胸骨切口感染发生率均无差异(P值均>0.05)。
  • 随访(5.4±2.8)年(范围:0.2~10.9年),1、5、10年全因病死率分别为2.3%、3.4%、6.9%,MACCE分别为3.9%、11.2%、28.5%,再次血运重建分别为0.4%、3.7%、11.9%。
  • 年龄>65岁是远期死亡的独立预后因素(HR=1.125,95%CI:1.050~1.205,P<0.01)。

关键数值与推荐

  • 左胸廓内动脉使用207例,右胸廓内动脉38例(双侧胸廓内动脉37例),桡动脉187例(188支)。

临床怎么用

  • 对合适选择的冠心病患者可采用全动脉化CABG,并结合个体化动脉移植物选择与手术策略。
  • 术后远期随访应关注MACCE和再次血运重建,年龄>65岁患者需加强远期风险管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To examine the short and long-term clinical outcomes of total arterial coronary artery bypass grafting. Methods: Clinic data of 208 patients with left main and multiple vessel coronary artery disease and undertaken total arterial coronary artery bypass grafting from February 2009 to December 2019 in Department of Cardiac Surgery, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine were analyzed retrospectively. There were 188 males and 20 females with an age of (54.7±10.7) years (range: 32 to 79 years). The harvest of arterial conduits and grafting strategies were depended upon the individual patient characteristics and surgeon's experience. Left internal thoracic artery (LITA) was applied in 207 cases, right internal thoracic artery (RITA) in 38 cases (bilateral internal thoracic artery (BITA) in 37 cases), and radial artery (RA) in 187 cases (188 grafts). The graft number per case was 2.6±0.7 (range: 2 to 4). Surgical procedures was completed with off-pump technique in 98.1% patients (204/208). Subgroup analysis was carried out between subgroup BITA (n=37) and subgroup SITA (single ITA+RA) (n=171). The t test, χ(2) test or Fisher exact test were used to compare the clinic characteristics between the two subgroups. The Kaplan-Meier curve was used to estimate the rate of late mortality, major adverse cardiac cerebrovascular event (MACCE), and target vessel revascularization (TVR). A Cox proportional hazards model was used to identify the independent prognosis factors of late mortality. Results: The overall mortality within 30 days postoperatively was 1.4%(3/208). The incidences of perioperative MACCE, re-operation for bleeding and deep sternal wound infection (DSWI) were 1.9%(4/208), 0.5%(1/208) and 1.4%(3/208), respectively. Perioperative myocardial infarction and TVR were not observed. There was no significant difference of 30-day mortality, MACCE, bleeding and DSWI between subgroup BITA and SITA+RA (all P>0.05). In a follow-up period of (5.4±2.8)years (range: 0.2 to 10.9 years), the incidence of all-cause mortality at 1-, 5- and 10-year was 2.3%, 3.4% and 6.9%, respectively. The incidence of MACCE was 3.9%,11.2% and 28.5%, respectively. The rate of TVR was 0.4%, 3.7% and 11.9%, respectively. Age>65 was an independent prognosis factor of late mortality (HR=1.125, 95% CI:1.050 to 1.205, P<0.01). Conclusions: Total arterial coronary bypass grafting is safe and achievable with proper patient selection and surgical strategies. It significantly decreases the risks of late mortality and repeated revascularization. 目的: 探讨全动脉化冠状动脉旁路移植术(CABG)的近期和远期疗效。 方法: 回顾性分析2009年2月至2019年12月上海交通大学医学院附属瑞金医院心脏外科实施的208例全动脉化CABG的冠心病患者的临床资料。男性188例,女性20例,年龄(54.7±10.7)岁(范围:32~79岁)。个体化选择动脉血管移植物并制定手术策略,其中使用左胸廓内动脉207例,右胸廓内动脉38例(双侧胸廓内动脉37例),桡动脉187例(188支),每例患者移植血管(2.6±0.7)支(范围:2~4支)。非体外循环CABG占98.1%(204/208)。将患者分为双侧组(37例,使用双侧胸廓内动脉加或不加桡动脉)和单侧组(171例,仅使用一侧胸廓内动脉和桡动脉)进行分析。组间比较采用t检验、χ(2)检验或Fisher确切概率法。绘制Kaplan-Meier生存曲线并估算远期全因病死率、主要严重心脑血管事件(MACCE)发生率和再次血运重建率。Cox回归分析远期死亡的独立预后因素。 结果: 总体术后30 d病死率为1.4%(3/208),MACCE发生率为1.9%(4/208),出血二次开胸发生率为0.5%(1/208),深部胸部切口感染发生率为1.4%(3/208),围手术期无心肌梗死和再次血运重建。双侧组与单侧组患者术前基线数据无差异,总体术后30 d病死率,MACCE、出血、深部胸骨切口感染发生率均无差异(P值均>0.05)。术后随访(5.4±2.8)年(范围:0.2~10.9年),1、5和10年全因病死率分别为2.3%、3.4%和6.9%,MACCE发生率分别为3.9%、11.2%和28.5%,再次血运重建率分别为0.4%、3.7%和11.9%。年龄>65岁是远期死亡的独立预后因素(HR=1.125,95% CI:1.050~1.205,P<0.01)。 结论: 选择合适的患者、制定个体化手术方案,全动脉化CABG是安全、可行的,可降低远期病死率和再次血运重建风险。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhao Q, Liu J, Ye XF, et al. [Surgical strategies and long-term outcomes of total arterial coronary artery bypass grafting: a series of 208 patients]. Zhonghua Wai Ke Za Zhi. 2020. PMID: 32393002. doi:10.3760/cma.j.cn112139-20200131-00054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。